Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Bridgewater Associates180,092주2026-06-30
- Fairholme Capital Management231,000주2026-06-30
Pfizer company information
화이자NYSE:PFE · New York Stock Exchange · Healthcare$27.80-1.14%
2026-10-02 closePfizer's company information is shown as of 2026-10-02. It is a security listed on New York Stock Exchange, ticker PFE. There are 14 published related companies.
About this company
Pfizer last closed at $27.80 (-1.14%) on 2026-10-02. Signals today: Near 52-week high, VCP. Listed on New York Stock Exchange.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
Other stocks held by the same investors
A filing-based shared-holder record, not investment advice.
- AppleUSAAPL-US →
Shared holders: Fairholme Capital Management
- Berkshire Hathaway Class AUSBRK.A-US →
Shared holders: Fairholme Capital Management
- Campbell SoupUSCPB-US →
Shared holders: Fairholme Capital Management
- Home BancSharesUSHOMB-US →
Shared holders: Fairholme Capital Management
- St JoeUSJOE-US →
Shared holders: Fairholme Capital Management
- Bank OzkUSOZK-US →
Shared holders: Fairholme Capital Management
- ProgressiveUSPGR-US →
Shared holders: Fairholme Capital Management
- United Parcel Service Class BUSUPS-US →
Shared holders: Fairholme Capital Management
Suppliers, competitors and related stocks
- ModernaCompetitor
mRNA 백신/치료제 분야의 핵심 경쟁사
- MerckCompetitor
항암제·백신·면역질환 분야에서 경쟁하는 대형 제약사
- Johnson & JohnsonCompetitor
종합 헬스케어·제약 부문에서 경쟁
- NovartisCompetitor
글로벌 대형 제약사로 주요 치료영역에서 경쟁
- AstraZenecaCompetitor
종양학·호흡기·희귀질환 등에서 경쟁하는 글로벌 제약사
- RocheCompetitor
종양학·진단·면역질환 분야의 글로벌 경쟁사
- BioNTechCompetitor
mRNA 기반 백신·항암 분야의 직접 경쟁사
- AbbVieCompetitor
면역질환·종양학 중심의 대형 바이오파마 경쟁사
- GSKCompetitor
백신·호흡기·감염병 치료제에서 경쟁
- AmgenCompetitor
바이오의약품 및 면역·종양 치료제에서 경쟁
- Eli LillyCompetitor
비만·당뇨·종양학 등 주요 고성장 치료영역 경쟁사
- Bristol Myers SquibbCompetitor
면역항암제·심혈관·혈액질환 분야 경쟁사
- SanofiCompetitor
백신·면역질환·희귀질환에서 경쟁하는 글로벌 제약사
- BiohavenRelated theme
편두통 등 신약 개발 테마에서 관련성이 있는 바이오 기업
Major stocks in the same sector
2026-10-03 dataset
📦 ETFs holding this stock
by weight · top-10 constituents basisPassive money holding this stock ≈ $4.5B(lower bound — top-10 basis, not a forecast)
- First Tr Morningstar Dividend Leaders Index Fund6.47%
- Franklin U.S. Dividend Booster Index ETF5.16%
- VanEck Pharmaceutical ETF5.05%
- Invesco Dynamic Pharmaceuticals ETF4.89%
- iShares Core High Dividend ETF4.73%
- iShares US Pharmaceuticals ETF4.48%
- Portfolio Building Block World Pharma and Biotech Index ETF3.60%
- Invesco S&P 500 High Div Low Volatility ETF3.40%
- First Trust Nasdaq Pharmaceuticals ETF3.27%
- ETC 6 Meridian Mega Cap Equity ETF2.93%
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →Quantus Signal · live data · not investment advice · Privacy Policy